Treatment Use Study of CP-675,206 for Advanced Melanoma
This is an expanded access trial that canceled prior to enrolling patients.
Expanded Access
N/A
Pfizer CT.gov Call Center
Study Director
Pfizer
United States: Food and Drug Administration
A3671028
NCT00584493
May 2008
Name | Location |
---|